These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 12414926)

  • 1. Comparison of molecular and biological characteristics of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (ingelvac PRRS MLV), the parent strain of the vaccine (ATCC VR2332), ATCC VR2385, and two recent field isolates of PRRSV.
    Opriessnig T; Halbur PG; Yoon KJ; Pogranichniy RM; Harmon KM; Evans R; Key KF; Pallares FJ; Thomas P; Meng XJ
    J Virol; 2002 Dec; 76(23):11837-44. PubMed ID: 12414926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a heteroduplex mobility assay to identify field isolates of porcine reproductive and respiratory syndrome virus with nucleotide sequences closely related to those of modified live-attenuated vaccines.
    Key KF; Guenette DK; Yoon KJ; Halbur PG; Toth TE; Meng XJ
    J Clin Microbiol; 2003 Jun; 41(6):2433-9. PubMed ID: 12791860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated immune response and protective efficacy of porcine reproductive and respiratory syndrome virus modified-live vaccines against co-challenge with PRRSV-1 and PRRSV-2.
    Madapong A; Saeng-Chuto K; Boonsoongnern A; Tantituvanont A; Nilubol D
    Sci Rep; 2020 Feb; 10(1):1649. PubMed ID: 32015495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune responses and protection by vaccine and various vaccine adjuvant candidates to virulent porcine reproductive and respiratory syndrome virus.
    Charerntantanakul W; Platt R; Johnson W; Roof M; Vaughn E; Roth JA
    Vet Immunol Immunopathol; 2006 Jan; 109(1-2):99-115. PubMed ID: 16165219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of two porcine reproductive and respiratory syndrome (PRRS) modified-live virus (MLV) vaccines against heterologous NADC30-like PRRS virus challenge.
    Chai W; Liu Z; Sun Z; Su L; Zhang C; Huang L
    Vet Microbiol; 2020 Sep; 248():108805. PubMed ID: 32828938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a 20year old porcine reproductive and respiratory syndrome (PRRS) modified live vaccine (Ingelvac(®) PRRS MLV) against two recent type 2 PRRS virus isolates in South Korea.
    Jeong J; Choi K; Kang I; Park C; Chae C
    Vet Microbiol; 2016 Aug; 192():102-109. PubMed ID: 27527771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics and evolution of porcine reproductive and respiratory syndrome virus (PRRSV) ORF5 following modified live PRRSV vaccination in a PRRSV-infected herd.
    Nilubol D; Tripipat T; Hoonsuwan T; Tipsombatboon P; Piriyapongsa J
    Arch Virol; 2014 Jan; 159(1):17-27. PubMed ID: 23851653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal and morphologic characterization of the distribution of porcine reproductive and respiratory syndrome virus (PRRSV) by in situ hybridization in pigs infected with isolates of PRRSV that differ in virulence.
    Haynes JS; Halbur PG; Sirinarumitr T; Paul PS; Meng XJ; Huffman EL
    Vet Pathol; 1997 Jan; 34(1):39-43. PubMed ID: 9150544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine efficacy of porcine reproductive and respiratory syndrome virus chimeras.
    Ellingson JS; Wang Y; Layton S; Ciacci-Zanella J; Roof MB; Faaberg KS
    Vaccine; 2010 Mar; 28(14):2679-86. PubMed ID: 20064475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy evaluation of three modified-live virus vaccines against a strain of porcine reproductive and respiratory syndrome virus NADC30-like.
    Zhou L; Yang B; Xu L; Jin H; Ge X; Guo X; Han J; Yang H
    Vet Microbiol; 2017 Aug; 207():108-116. PubMed ID: 28757009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of four types of MLV-derived porcine reproductive and respiratory syndrome viruses isolated in unvaccinated pigs from 2016 to 2020.
    Chen N; Li X; Xiao Y; Li S; Zhu J
    Res Vet Sci; 2021 Jan; 134():102-111. PubMed ID: 33360570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A porcine reproductive and respiratory syndrome virus candidate vaccine based on the synthetic attenuated virus engineering approach is attenuated and effective in protecting against homologous virus challenge.
    Evenson D; Gerber PF; Xiao CT; Halbur PG; Wang C; Tian D; Ni YY; Meng XJ; Opriessnig T
    Vaccine; 2016 Nov; 34(46):5546-5553. PubMed ID: 27742217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Fostera® PRRS modified live virus (MLV) vaccination strategy against a Thai highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) infection.
    Charoenchanikran P; Kedkovid R; Sirisereewan C; Woonwong Y; Arunorat J; Sitthichareonchai P; Sopipan N; Jittimanee S; Kesdangsakonwut S; Thanawongnuwech R
    Trop Anim Health Prod; 2016 Oct; 48(7):1351-9. PubMed ID: 27315207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a modified-live porcine reproductive and respiratory syndrome virus vaccine intervention on a population of pigs infected with a heterologous isolate.
    Cano JP; Dee SA; Murtaugh MP; Pijoan C
    Vaccine; 2007 May; 25(22):4382-91. PubMed ID: 17451850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of complete nucleotide sequence of porcine reproductive and respiratory syndrome virus (PRRSV) isolates in Thailand (US and EU genotypes).
    Amonsin A; Kedkovid R; Puranaveja S; Wongyanin P; Suradhat S; Thanawongnuwech R
    Virol J; 2009 Sep; 6():143. PubMed ID: 19754975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of porcine reproductive and respiratory syndrome virus-induced increase in susceptibility to Streptococcus suis infection.
    Thanawongnuwech R; Brown GB; Halbur PG; Roth JA; Royer RL; Thacker BJ
    Vet Pathol; 2000 Mar; 37(2):143-52. PubMed ID: 10714643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral immune responses and viral shedding following vaccination with modified live porcine reproductive and respiratory syndrome virus vaccines.
    Madapong A; Temeeyasen G; Saeng-Chuto K; Tripipat T; Navasakuljinda W; Boonsoongnern A; Tantituvanont A; Nilubol D
    Arch Virol; 2017 Jan; 162(1):139-146. PubMed ID: 27695957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-protective immunity to porcine reproductive and respiratory syndrome virus by intranasal delivery of a live virus vaccine with a potent adjuvant.
    Dwivedi V; Manickam C; Patterson R; Dodson K; Murtaugh M; Torrelles JB; Schlesinger LS; Renukaradhya GJ
    Vaccine; 2011 May; 29(23):4058-66. PubMed ID: 21419162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phylogenetic analysis and molecular characteristics of seven variant Chinese field isolates of PRRSV.
    Wang C; Wu B; Amer S; Luo J; Zhang H; Guo Y; Dong G; Zhao B; He H
    BMC Microbiol; 2010 May; 10():146. PubMed ID: 20482897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of routes of immunization of a live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine in a heterologous virus challenge study.
    Ouyang K; Hiremath J; Binjawadagi B; Shyu DL; Dhakal S; Arcos J; Schleappi R; Holman L; Roof M; Torrelles JB; Renukaradhya GJ
    Vet Res; 2016 Mar; 47():45. PubMed ID: 26988085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.